Aperion Biologics, Inc. — Form D
Aperion Biologics, Inc. of San Antonio, TX, a company, filed a Form D exempt-offering notice with the SEC on 2011-05-31. The offering totals $6.0M, of which $4.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-05-31
- Form: D
- Accession: 0001439026-11-000004
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $6.0M
- Amount sold: $4.5M
- Remaining: $1.5M
- Investors: 1
- Date of first sale: 2011-05-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-160541
Issuer
- Name: Aperion Biologics, Inc.
- CIK: 0001439026
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 11969 Starcrest Drive, San Antonio, TX, 78247
- Phone: 210.858.7070
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Al T Holcomb | Director | San Antonio, TX |
| Daniel R Lee | Director | Las Vegas, NV |
| Dugan R Schwalm | Director | San Antonio, TX |
| Kevin R Stone | Director | San Antonio, TX |
| William T White III | Director | Durham, NC |
| Daniel R Lee | Executive Officer | Las Vegas, NV |
More